JOANA DE GUSMÃO CHILDREN’S HOSPITAL/UNIVERSITY HOSPITAL FLORIANÓPOLIS-SC-BRAZIL.

Slides:



Advertisements
Similar presentations
CARDIOVASCULAR EFFECTS OF ANTHRACYCLINE-LIKE CHEMOTHERAPY AGENTS JOHN N. HAMATY FACC, FACOI.
Advertisements

Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Azin Alizadehasl, MD. Sarcoidosis is a systemic inflammatory disease of unknown etiology, characterized by non-caseating granulomas. It mainly affects.
Manoel Otávio da Costa Rocha UNIVERSIDADE FEDERAL DE MINAS GERAIS - FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE: INFECTOLOGIA.
Comparison of Echocardiographic Methods to Cardiac Magnetic Resonance Imaging in Survivors of Pediatric Cancer Jeet Mehta 1, Sanket Shah 1,2 Wendy McClellan.
Chemokine Receptor 5 Inhibition Prevents SIV-associated Cardiac Dysfunction Katie Kelly Brennan, DVM Johns Hopkins University School of Medicine Department.
HIV Disease in Older Patients Donna M. Gallagher, ANP The International AIDS Society–USA DM Gallagher, ANP. Presented at IAS–USA/RWCA Clinical Conference,
Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis Priscilla Y. Hsue, Peter W. Hunt, Jeffrey N. Martin, Amanda Schnell,
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Primary Myocardial Disease Dr. Raid Jastania. Case.
Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Cardiac Issues in Friedreich’s Ataxia 2 nd Annual Friedreich’s Ataxia Symposium Robert E. Shaddy, MD Jennifer Terker Professor of Pediatrics Division Chief,
DIASTOLIC DYSFUNCTION AND HEART FAILURE PHYSIOLOGY, HISTORICAL FEATURES AND CLINICAL PERSPECTIVE Medicine Resident Rounds September 28, 2007 Jacobi Hospital.
Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Human Immunodeficiency Virus Part II VIRUSES. TYPES OF HIV There are two types of HIV HIV-1 and HIV-2 Can be distinguished genetically and antigenically.
Ventricular Diastolic Filling and Function
Heart Failure John Lynn Jefferies, MD, MPH, FAAP, FACC Director, Cardiomyopathy, Advanced Heart Failure, and Ventricular Assist Device Programs Co-Director,
Duchenne Muscular Dystrophy: Cardiac Management. Introduction Aim: early detection and treatment of deterioration in heart muscle function Cardiac disease.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Effect of ivabradine on recurrent hospitalization for worsening heart failure: findings from SHIFT S ystolic H eart failure treatment with the I f inhibitor.
Multiple Choice Questions for discussion
Effectiveness of Micronutrient-rich Lipid Nutrient Supplements in Delaying Clinical Progression of HIV in Malawian Adults Heidi Sandige, MD.
The method for evaluating cardiac function by echocardiography
Measurement Measuring disease and death frequency FETP India.
Measuring disease and death frequency
Diastolic Dysfunction is Common in Asymptomatic HIV Patients Priscilla Y. Hsue 1,2, Husam H. Farah 1,2, Ann F. Bolger 1,2, Swapna Palav 2, Samira Ahmed.
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Effect of ivabradine on recurrent hospitalization for worsening heart failure: findings from SHIFT S ystolic H eart failure treatment with the I f inhibitor.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of.
1 Predictors of Cardiac Dysfunction among Children and Adolescents Perinatally-Infected with HIV-1. Kunjal Patel, Murray A. Mittleman, Steven D. Colan,
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Efficacy and safety of ivabradine in patients with severe chronic systolic.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Presenter Disclosure Information Echocardiographic Tissue Doppler Imaging Is a Powerful Independent Prognosticator of Overall Mortality in the General.
1 The impact of ongoing illicit drug use on virologic suppression in HIV-infected injection drug users receiving HAART Authors: Harout Tossonian, Jesse.
Guidelines for the Echocardiographic Assessment of
1 ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION BY TISSUE DOPPLER IMAGING SHOWS EVIDENCE OF SUBCLINICAL CARDIOMYOPATHY EARLY AFTER ATHRACYCLINE THERAPY.
Systolic Versus Diastolic Failure. Forms of Heart Failure Sytolic Failure Inability of the ventricle to contract normally and expel sufficient blood Inadequate.
HIV DISEASE IN PREGNANCY
Myocarditis: toward a better understanding for an improved diagnosis January 16 th, h-10h30.
Thomas Wilson 1,2,3, Vijay Krishnamoorthy MD 1,2, Edward Gibbons MD 4, Ali Rowhani-Rahbar MD MPH PhD 2,5, Adeyinka Adedipe MD 6, Monica S. Vavilala MD.
Introduction BACKGROUND  N on-sustained VT (NSVT) is a known risk factor for poor outcomes in adults with HCM and diastolic dysfunction is linked to poor.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Phenotypes of Familial Dilated Cardiomyopathy.
以多重死因資料比較台灣美國腦中風 併發吸入性肺炎之趨勢 奇美醫學中心 張嘉祐醫師. Stroke Statistics -- A Report From the American Heart Association Approximately 56% of stroke deaths in 2009.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients with Heart Failure with preserved Ejection Fraction Effect of Spironolactone.
P-wave Dispersion and Diastolic Function in Pubertal Type 1 Diabetic Children P6:T1 Maha Amin1, Yasser Hussein Kamel2, Amany Ibrahim1, Fawzia Salim Ali.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Heart & Thalassemia . R.Miri,MD, Interventional Cardiologist.
These slides highlight a presentation at the Late Breaking Trial Session of the American College of Cardiology 52nd Annual Scientific Sessions in Chicago,
– р<0.05 between baseline
Acromegaly is characterized by excessive growth hormone (GH) secretion and is primarily caused by a GH-secreting pituitary adenoma, which stimulates.
The Anglo Scandinavian Cardiac Outcomes Trial
Evaluation of Left Ventricular Enlargement as a Marker of Early Disease in Familial Dilated CardiomyopathyClinical Perspective by Diane Fatkin, Thomas.
A, Breakdown of frailty into its underlying causes, manifestations, and clinical outcomes separated by LVAD-responsive and LVAD-independent causes of frailty.
The percentage of subjects with de novo development of renal function impairment (GFR
Diastolic heart failure
Echocardiography findings in HFNEF
ß-blocker therapy for heart failure at the turn of the millennium
Correlation between endothelial function and hypertension
Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effect of ivabradine on recurrent hospitalization for worsening heart failure:
قطب قلب اصفهان 12/8/2016.
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Presentation transcript:

JOANA DE GUSMÃO CHILDREN’S HOSPITAL/UNIVERSITY HOSPITAL FLORIANÓPOLIS-SC-BRAZIL

CARDIAC DIASTOLIC FUNCTION IN PEDIATRIC AIDS/HIV-CARRIERS: ASSESSMENT, TREATMENT AND PREVENTION OF FUTURE CARDIOVASCULAR DISEASES MAURICIO LAERTE SILVA,MD

BEFOREBEFORE AFTERAFTER

Cardiovascular manifestations occur frequently in children with human immunodeficiency virus (HIV) vertical infection. The prevalence of HIV infection among children is still high as advances in therapy and management of the disease improve life expectancy. J Pediatr 2002;141(3): ;Pediatrics 2001;107:

 In a prospective study, the 5-year cumulative incidence of cardiac dysfunction in children ranged from 18% to 39%. underlying cause of HIV-related death in 11.8% of them.  The exact pathogenesis of the cardiac manifestations remains unclear. most likely multifactorial. Pediatrics 2001;107:328-38; J Pediatr 2002;141(3):327-34;Circ Heart Fail 2010;3(1):132-9.

The cardiac abnormality most commonly seen is dilated cardiomyopathy. ranging from asymptomatic cardiac dilation to severe chronic heart failure. Mild depression of left ventricle (LV) and LV mass were risk factors for death, independent of age, duration of illness, CD 4 + count, HIV-1 viral load, neurologic disease or malnutrition. J Pediatr 2002;141(3):327-34; Pediatrics 2001;107:328-38;AIDS 2003;17(Suppl. 1):S46–S50; Circulation 2000;102:1542-8; Pediatr Infect Dis J 2004;23(6):

Subclinical cardiac abnormalities develop early in HIV-infected children, even among those with asymptomatic HIV disease or for cardiac dysfunction. J Pediatr 2002;141(3):327-34; Circulation 2000;102:1542-8;Indian Pediatr 2005 ;42(2):146-9; Afr Health Sci 2005;5(3):219-26; Cardiovasc J S Afr 2005;16(4):

After beginning highly active antiretroviral therapy (HAART), there are reports of reductions in the incidence of left ventricular dysfunction and more favourable outcomes of cardiac alterations. It was reported the resolution of dilated cardiomyopathy in vertically-infected HIV affected children who received a combination of drugs. Pediatr Infect Dis J 2004;23(6):559-63; Arq Bras Cardiol 2008;90(1):11-7;Arq Bras Cardiol 2003;80(3):316-20; Arq Bras Cardiol 2005;85(4):

It is possible that an alteration in diastolic function precedes systolic dysfunction, as seen in other clinical conditions Heart 2000;84(6):620-4; AIDS Patient Care STDS 2009 ;23(4):231-8; Circ Heart Fail 2010;3(1):132-9.

An observational, cross-sectional study was conducted at the Joana de Gusmao Children's Hospital, Santa Catarina Health State Secretary, Brazil. Convenience and not probabilistic sample.* *Silva,ML et al. Biventricular diastolic function assessed by Doppler echocardiogram in children vertically infected with human immunodeficiency vírus. J Pediatr (Rio J). 2014;90(4);

94 symptomatic (CDC classes A, B or C) vertically HIV-infected children. Age: 20.3 to months (mean 69.7 months). Sex: 52 (55.0%) males. J Pediatr (Rio J). 2014;90(4):

Two diastolic cardiac function variables were evaluated: Left and right ventricular filling, represented by the E/A ratio of the mitral and tricuspid Doppler waveforms. E A E/A ratio > 1,0 A E/A ratio < 1,0 E NORMAL ABNORMAL J Pediatr (Rio J). 2014;90(4):

In the left heart side, there was a predominance of the myocardial compliance impairment (28.0% and 95%CI, 18.9% to 37.1%) versus the abnormal relaxation (10.7% and 95% Cl, 4.4% to 17.0%). J Pediatr (Rio J). 2014;90(4):

In the right heart side, the situation was reversed, and was evidente a slight predominance of the abnormal relaxation (16.3% and 95% Cl, 8.7% to 23.7%) in comparison to the myocardial compliance impairment (13.1% and 95% CI, 6.2% to 20.0%) J Pediatr (Rio J). 2014;90(4):

From the physiopathologic standpoint, the abnormal relaxation represents an impairment of myocardial relaxation and/or filling dynamics of ventricles and is an early and reversible stage in the scope of the diastolic dysfunction. However, the myocardial compliance impairment is due to a more aggressive injury of the myocardium, sometimes with fibrosis, and may not be reversible in some instances. J Pediatr (Rio J). 2014;90(4):

Why differences in the type of diastolic dysfunction between the left and right ventricles exist is a question that remains to be clarified. Therefore, it appears that the left myocardium is more susceptible to the aggression, regardless the causal agent, or it is affected early during the disease progression. J Pediatr (Rio J). 2014;90(4):

The exploratory procedures (factorial analysis and multiple correspondence analysis) to evaluate correlations between variables did not show evidence of any association, despite some suggestions from the table of frequency analysis. J Pediatr (Rio J). 2014;90(4):

Thus, the findings of biventricular diastolic dysfunction may be an expression of an isolated direct or indirect action of the HIV with no influence of any other factor, as has been suggested by other authors. J Pediatr (Rio J). 2014;90(4):

The fact that the immunologic status did not show a relationship with cardiac dysfunction is important clinically and indicates that the CD 4 + percentage count cannot be considered an indicator of cardiac involvement. J Pediatr (Rio J). 2014;90(4):

Thus, HIV-infected children should have a Doppler-echocardiographic study performed as a part of their evaluation, even when they are asymptomatic from the cardiovascular point of view. J Pediatr (Rio J). 2014;90(4):

SUMMARIZING

Adapted from: Cardiovascular disease in AIDS.Springer Milan.2009, pp Phase of diastolic dysfunction (inversion of the E/A ratio and prolongation of the isovolumetric relaxation time) with normal systolic parameter (Fractional Shortening > 27% (EF >50%) Potentially reversible Need chocardiographic follow-up every six months EVOLUTION AND PATHOGENESIS OF THE INVOLVEMENT OF THE CARDIOVASCULAR SYSTEM IN HIV INFECTION PHASE I

Adapted from:Cardiovascular disease in AIDS.Springer Milan.2009, pp Phase of reversible systolic dysfunction (increase of thickness of interventricular septum, increase of end-diastolic diameter, optimal thickness/radium ratio), with a Fractional Shortening > 27% (EF >50%) Potentially reversible but duration unpredictable. Improvement of the echocardiographic parameters with ACE-1 inhibitors. Immunomodulant therapy (eg. iv immunoglobulin) may be helpful in case of myocarditis and viral myocardial infection. In this phase the use of AZT may worsen the clinical evolution of cardiomyopathy (possibly for impairment of the Krebs cycle). Need echocardiographic folow-up every six months. PHASE II

Phase of irreversible systolic dysfunction (increase of both end-diastolic and end-systolic diameter, flattening of the interventricular septum without systolic increase, difuse left ventricular hypokinesia) with a Fractional Shortening < 27% (EF <40%) Non reversible. In this phase individual variables (including HAART) may accelerate the negative outcome of cardiomyiopathy. The state of immunodeficiency may enhance the negative inotropic effects of local cytokines, justifying the reduced response to inotropic agents. Adapted from:Cardiovascular disease in AIDS.Springer Milan.2009, pp PHASE III

Prevention! = screening

THANK YOU SO MUCH FOR YOUR ATTENTION!